Simvastatin/Nicotinic Acid

辛伐他汀/烟酸

Report date: 2023/04/25 14:17:10

Base Information

Drug NameSimvastatin/Nicotinic Acid
Drug Alias Name烟酸辛伐他汀Nicotinic Acid and Simvastatin辛伐他汀/烟酸Niacin/SimvastatinNiacin and Simvastatin +[12] 
ClassificationSmall molecules
Mechanisms of ActionHMG-CoA reductase inhibitorsHydroxycarboxylic acid receptor 2 agonistsHM74 nicotinic acid GPCR agonists
TargetsHMG-CoA reductaseHydroxycarboxylic acid receptor 2HM74 nicotinic acid GPCR
Therapy Area/IndicationsHypertriglyceridemiaHypercholesterolemiaHyperlipidemias +[4] 
Global Approved IndicationsDyslipidemias
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2008/02/15
Country/TerritoryUnited StatesMainland China
CombinationsYes SimvastatinNicotinic Acid
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesShandong Bestcomm Pharmaceutical Company Ltd
Inactive CompaniesAbbott LaboratoriesAbbvie IncKos Pharmaceuticals Inc
Active IndicationsHypertriglyceridemiaHypercholesterolemiaDyslipidemias
Inactive IndicationsHyperlipidemias

Other Information

ATC CodeC10AD52
Related LinksWikipedia